Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

Genomic Health Inc. (GHDX)

-NasdaqGS

37.24 May 21, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 63,094   60,427   58,648   57,631  
Cost of Revenue9,746  9,641  9,037  9,014  
Gross Profit 53,348   50,786   49,611   48,617  
Operating Expenses
Research Development13,663  13,329  12,267  11,579  
Selling General and Administrative40,574  35,442  33,633  35,201  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (889) 2,015   3,711   1,837  
Income from Continuing Operations
Total Other Income/Expenses Net59  123  110  2  
Earnings Before Interest And Taxes(830)2,138  3,821  1,839  
Interest Expense -   -   -   -  
Income Before Tax(830)2,138  3,821  1,839  
Income Tax Expense53  179  108  39  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(883)1,959  3,713  1,800  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (883) 1,959   3,713   1,800  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (883) 1,959   3,713   1,800  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.